Online Only Articles

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
Department of Hematology, University Hospital, Nantes, France
Department of Hematology, University Hospital, Nantes, France
Department of Hematology, University Hospital, Nantes, France
Department of Hematology, University Hospital, Nantes, France
Biochemistry Laboratory, University Hospital, Nantes, France
Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
Vol. 102 No. 3 (2017): March, 2017 https://doi.org/10.3324/haematol.2016.160408